About this trial
To assess the hemodynamic difference after spinal anesthesia with hyperbaric bupivacaine and isobaric bupivacaine in elective cesarean section
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
ASA II parturient with normal pregnancy Parturients undergoing elective cesarean section under spinal anesthesia Parturient refusing normal trial of labor, planned for ELLSCS under spinal anesthesia
Disqualifiers
Patient refusal Parturient with known drug allergy to local anesthetics Parturients undergoing emergency cesarean section Spinal anesthesia converted to general anesthesia.
Trial design
Parallel
Treatments tested in this trial
Spinal anesthesia with hyperbaric bupivacaine
DrugSpinal anesthesia with hyperbaric bupivacaine according to height
Spinal anesthesia with isobaric bupivacaine
DrugSpinal anesthesia with Isobaric bupivacaine according to height
Treatment groups
Trial outcomes
Primary outcomes
Maternal hypotension
Incidence of maternal hypotension (MAP \< 60 mm Hg or drop in MAP \> 20% of the baseline) within 5 minutes after intrathecal drug administration
Secondary outcomes
Maternal heart rate trend
Maternal heart rate as bpm
Use of vasopressors
Requirement for vasopressors
Nausea and vomiting
incidence of nausea/vomiting due to hypotension
APGAR score
Fetal Apgar scores at 1 and 5 minutes
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
This trial is not recruiting at the moment. You can still explore other options: